Growth Metrics

Omeros (OMER) EBIT Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 12.69%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 75.16%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -347.04%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 80.62%
7 Evaxion A 62.56 Bn 62.54 Bn - 1.27%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 8.65%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1,386.07%
10 Omeros 772.03 Mn 636.71 Mn 9.31 Mn 50.18%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 50.18%
Dec 31, 2025 12.81%
Sep 30, 2025 25.46%
Jun 30, 2025 45.31%
Mar 31, 2025 10.41%
Dec 31, 2024 16.12%
Sep 30, 2024 26.47%
Jun 30, 2024 -44.64%
Mar 31, 2024 -9.30%
Dec 31, 2023 0.93%
Sep 30, 2023 5.15%
Jun 30, 2023 -9.24%
Mar 31, 2023 -1.90%
Dec 31, 2022 6.41%
Sep 30, 2022 -27.46%
Jun 30, 2022 17.92%
Mar 31, 2022 22.62%
Dec 31, 2021 -26.83%
Sep 30, 2021 -56.63%
Jun 30, 2021 -64.78%
Mar 31, 2021 -91.28%
Dec 31, 2020 -42.66%
Sep 30, 2020 -129.06%
Jun 30, 2020 -196.42%
Mar 31, 2020 -23.07%
Dec 31, 2019 -28.31%
Sep 30, 2019 68.68%
Jun 30, 2019 69.50%
Mar 31, 2019 30.52%
Dec 31, 2018 -30.83%
Sep 30, 2018 -593.58%
Jun 30, 2018 -156.45%
Mar 31, 2018 -117.60%
Dec 31, 2017 -19.09%
Sep 30, 2017 57.55%
Jun 30, 2017 -9.24%
Mar 31, 2017 34.58%
Dec 31, 2016 34.27%
Sep 30, 2016 37.63%
Jun 30, 2016 31.55%
Mar 31, 2016 -8.49%
Dec 31, 2015 9.69%
Sep 30, 2015 -12.66%
Jun 30, 2015 7.26%
Mar 31, 2015 -14.32%
Dec 31, 2014 -43.68%
Sep 30, 2014 -27.53%
Jun 30, 2014 -30.83%
Mar 31, 2014 -56.53%
Dec 31, 2013 -84.55%
Sep 30, 2013 -3.05%
Jun 30, 2013 -59.63%
Mar 31, 2013 -24.13%
Dec 31, 2012 23.50%
Sep 30, 2012 -111.49%
Jun 30, 2012 -66.58%
Mar 31, 2012 -25.15%
Dec 31, 2011 -15.08%
Sep 30, 2011 17.70%
Jun 30, 2011 35.17%